the present invention furthermore relates to a BPC peptide salt or a pharmaceutical or diagnostic composition according to the above wherein the general formula (II) is the present invention relates in particular to a BPC peptide salt or a pharmaceutical or diagnostic composition a BPC peptide salt or a pharmaceutical or diagnostic composition comprising a salt of a BPC peptide according to the above general formula (I) wherein the peptide is selected from the group consisting of: the peptides may be linked to other functional and/or structural moieties such as carbohydrates, fats, proteins or peptides, antibodies, receptors, hormones, cytotoxic substances, marker substances, dyes, radioactive labels, immunomodulatory agents, drugs, carriers, targeting or signalling substances, etc
Constipation affects a significant percentage of tirzepatide users
Hepatology 74 , 33013315 (2021)
Use of Glucagon-Like Peptide-1 Receptor Agonists in People With History of Acute Pancreatitis: TriNetX Analysis
